The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 18, 2022

Filed:

Oct. 19, 2021
Applicant:

George Mason Research Foundation, Inc., Fairfax, VA (US);

Inventors:

Brian Hetrick, Manassas, VA (US);

Yuntao Wu, Manassas, VA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C12N 15/86 (2006.01); C12N 7/00 (2006.01); A01N 63/00 (2020.01); A61K 39/12 (2006.01); C12N 9/02 (2006.01); A61K 39/215 (2006.01); C12Q 1/6897 (2018.01);
U.S. Cl.
CPC ...
C12N 7/00 (2013.01); A61K 39/215 (2013.01); C12N 9/0069 (2013.01); C12N 15/86 (2013.01); C12Q 1/6897 (2013.01); C12N 2770/20023 (2013.01); C12N 2770/20071 (2013.01); C12N 2770/36121 (2013.01); C12N 2770/36143 (2013.01);
Abstract

Timely development of vaccines and antiviral drugs is critical to control the COVID-19 pandemic. Current methods for quantifying vaccine-induced neutralizing antibodies involve the use of pseudoviruses, such as the SARS-CoV-2 spike protein (S) pseudotyped lentivirus. However, these pseudoviruses contain structural proteins foreign to SARS-CoV-2, and require days to infect and express reporter genes. Here, the present application discloses composition and methodology for making and using a new hybrid alphavirus-SARS-CoV-2 (Ha-CoV-2) particle for rapid and accurate quantification of neutralization antibodies and viral variants.


Find Patent Forward Citations

Loading…